{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T02:16:58Z","timestamp":1789179418546,"version":"build-2803163510"},"reference-count":30,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T00:00:00Z","timestamp":1762128000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100013995","name":"Genzyme Corporation","doi-asserted-by":"publisher","award":["E005033672"],"award-info":[{"award-number":["E005033672"]}],"id":[{"id":"10.13039\/100013995","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Genetics and Metabolism"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.ymgme.2025.109286","type":"journal-article","created":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T22:42:20Z","timestamp":1762209740000},"page":"109286","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Correlation of Plasma Lyso-GL1 Levels with Clinical Phenotype and Treatment Decisions in Patients with Gaucher Disease"],"prefix":"10.1016","volume":"146","author":[{"given":"Chloe","family":"Cheung","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Fierro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"McDonough","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chanan","family":"Stauffer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel","family":"Kaplan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louise","family":"Bier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunli","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel","family":"Evard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaya","family":"Ganesh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manisha","family":"Balwani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ymgme.2025.109286_bb0005","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1002\/ajh.21888","article-title":"A reappraisal of Gaucher disease-diagnosis and disease management algorithms","volume":"86","author":"Mistry","year":"2011","journal-title":"Am. J. Hematol."},{"issue":"2","key":"10.1016\/j.ymgme.2025.109286_bb0010","doi-asserted-by":"crossref","DOI":"10.3390\/ijms18020441","article-title":"A review of Gaucher disease pathophysiology, clinical presentation and treatments","volume":"18","author":"Stirnemann","year":"2017","journal-title":"Int. J. Mol. Sci."},{"issue":"11","key":"10.1016\/j.ymgme.2025.109286_bb0015","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1002\/humu.21327","article-title":"Experience with carrier screening and prenatal diagnosis for 16 Ashkenazi Jewish genetic diseases","volume":"31","author":"Scott","year":"2010","journal-title":"Hum. Mutat."},{"issue":"9645","key":"10.1016\/j.ymgme.2025.109286_bb0020","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1016\/S0140-6736(08)61522-6","article-title":"Phenotype, diagnosis, and treatment of Gaucher\u2019s disease","volume":"372","author":"Grabowski","year":"2008","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.ymgme.2025.109286_bb0025","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1038\/gim.2016.159","article-title":"Early manifestations of type 1 Gaucher disease in presymptomatic children diagnosed after parental carrier screening","volume":"19","author":"Yang","year":"2017","journal-title":"Genet. Med."},{"issue":"16","key":"10.1016\/j.ymgme.2025.109286_bb0030","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1001\/archinternmed.2010.302","article-title":"Type 1 Gaucher disease: significant disease manifestations in \u201casymptomatic\u201d homozygotes","volume":"170","author":"Balwani","year":"2010","journal-title":"Arch. Intern. Med."},{"issue":"10","key":"10.1016\/j.ymgme.2025.109286_bb0035","doi-asserted-by":"crossref","DOI":"10.3390\/jcm8101662","article-title":"Long term follow-up of 103 untreated adult patients with type 1 Gaucher disease","volume":"8","author":"Dinur","year":"2019","journal-title":"J. Clin. Med."},{"issue":"11","key":"10.1016\/j.ymgme.2025.109286_bb0040","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1001\/jama.298.11.1329","article-title":"Carrier screening for Gaucher disease: more harm than good?","volume":"298","author":"Beutler","year":"2007","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/j.ymgme.2025.109286_bb0045","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1111\/bjh.15402","article-title":"How we manage Gaucher disease in the era of choices","volume":"182","author":"Revel-Vilk","year":"2018","journal-title":"Br. J. Haematol."},{"issue":"Suppl. 5","key":"10.1016\/j.ymgme.2025.109286_bb0050","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1053\/j.seminhematol.2004.07.010","article-title":"Gaucher disease type 1: revised recommendations on evaluations and monitoring for adult patients","volume":"41","author":"Weinreb","year":"2004","journal-title":"Semin. Hematol."},{"issue":"9","key":"10.1016\/j.ymgme.2025.109286_bb0055","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1002\/humu.20524","article-title":"Type 1 Gaucher disease: null and hypornorphic novel chitotriosidase mutations - implications for diagnosis and therapeutic monitoring","volume":"28","author":"Grace","year":"2007","journal-title":"Hum. Mutat."},{"issue":"11","key":"10.1016\/j.ymgme.2025.109286_bb0060","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1002\/ajh.24491","article-title":"Glucosylsphingosine is a key biomarker of Gaucher disease","volume":"91","author":"Murugesan","year":"2016","journal-title":"Am. J. Hematol."},{"issue":"16","key":"10.1016\/j.ymgme.2025.109286_bb0065","doi-asserted-by":"crossref","DOI":"10.1182\/blood-2011-05-352971","article-title":"Elevated plasma glucosylsphingosine in Gaucher disease: relation to phenotype, storage cell markers, and therapeutic response","volume":"118","author":"Dekker","year":"2011","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.ymgme.2025.109286_bb0070","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20123033","article-title":"Glucosylsphingosine (lyso-Gb1) as a biomarker for monitoring treated and untreated children with Gaucher disease","volume":"20","author":"Hurvitz","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ymgme.2025.109286_bb0075","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.cca.2015.07.026","article-title":"Rapid, single-phase extraction of glucosylsphingosine from plasma: a universal screening and monitoring tool","volume":"450","author":"Fuller","year":"2015","journal-title":"Clin. Chim. Acta"},{"issue":"11","key":"10.1016\/j.ymgme.2025.109286_bb0080","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0079732","article-title":"Glucosylsphingosine is a highly sensitive and specific biomarker for primary diagnostic and follow-up monitoring in Gaucher disease in a non-Jewish, Caucasian cohort of Gaucher disease patients","volume":"8","author":"Rolfs","year":"2013","journal-title":"PLoS One"},{"issue":"19","key":"10.1016\/j.ymgme.2025.109286_bb0085","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/ijms21197159","article-title":"Value of Glucosylsphingosine (Lyso-Gb1) as a biomarker in Gaucher disease: a systematic literature review","volume":"21","author":"Revel-Vilk","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"4","key":"10.1016\/j.ymgme.2025.109286_bb0090","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24043945","article-title":"Contribution of Glucosylsphingosine (Lyso-Gb1) to treatment decisions in patients with Gaucher disease","volume":"24","author":"Dinur","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"6","key":"10.1016\/j.ymgme.2025.109286_bb0095","doi-asserted-by":"crossref","first-page":"E140","DOI":"10.1002\/ajh.25074","article-title":"Glucosylsphingosine is a reliable response biomarker in Gaucher disease","volume":"93","author":"Arkadir","year":"2018","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.ymgme.2025.109286_bb0100","first-page":"27","article-title":"The role of glucosylsphingosine as an early indicator of disease progression in early symptomatic type 1 Gaucher disease","author":"Stiles","year":"2021","journal-title":"Mol. Genet. Metab. Rep."},{"issue":"5","key":"10.1016\/j.ymgme.2025.109286_bb0105","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1213\/ANE.0000000000002864","article-title":"Correlation coefficients: appropriate use and interpretation","volume":"126","author":"Schober","year":"2018","journal-title":"Anesth. Analg."},{"issue":"3","key":"10.1016\/j.ymgme.2025.109286_bb0110","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1172\/JCI117084","article-title":"Marked elevation of plasma chitotriosidase activity. A novel hallmark of Gaucher disease","volume":"93","author":"Hollak","year":"1994","journal-title":"J. Clin. Invest."},{"issue":"40","key":"10.1016\/j.ymgme.2025.109286_bb0115","doi-asserted-by":"crossref","first-page":"25680","DOI":"10.1074\/jbc.273.40.25680","article-title":"The human chitotriosidase gene. Nature of inherited enzyme deficiency","volume":"273","author":"Boot","year":"1998","journal-title":"J. Biol. Chem."},{"issue":"5","key":"10.1016\/j.ymgme.2025.109286_bb0120","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1515\/cclm-2019-0949","article-title":"LC-MS\/MS analysis of plasma glucosylsphingosine as a biomarker for diagnosis and follow-up monitoring in Gaucher disease in the Spanish population","volume":"58","author":"Ir\u00fan","year":"2020","journal-title":"Clin. Chem. Lab. Med."},{"issue":"3","key":"10.1016\/j.ymgme.2025.109286_bb0125","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1002\/jimd.12192","article-title":"Expanding the clinical utility of glucosylsphingosine for Gaucher disease","volume":"43","author":"Saville","year":"2020","journal-title":"J. Inherit. Metab. Dis."},{"issue":"11","key":"10.1016\/j.ymgme.2025.109286_bb0130","first-page":"683","article-title":"An update of Gaucher mutations distribution in the Ashkenazi Jewish population: prevalence and country of origin of the mutation R496H","volume":"16","author":"Bronstein","year":"2014","journal-title":"Isr. Med. Assoc. J."},{"issue":"1","key":"10.1016\/j.ymgme.2025.109286_bb0135","doi-asserted-by":"crossref","DOI":"10.1016\/j.ymgme.2023.107736","article-title":"Treatment-naive and post-treatment glucosylsphingosine (lyso-GL1) levels in a cohort of pediatric patients with Gaucher disease","volume":"141","author":"Rasmussen","year":"2024","journal-title":"Mol. Genet. Metab."},{"issue":"13","key":"10.1016\/j.ymgme.2025.109286_bb0140","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/ijms21134577","article-title":"Treatment efficiency in Gaucher patients can reliably be monitored by quantification of Lyso-Gb1 concentrations in dried blood spots","volume":"21","author":"Cozma","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.ymgme.2025.109286_bb0145","doi-asserted-by":"crossref","first-page":"25","DOI":"10.4097\/kja.21209","article-title":"Receiver operating characteristic curve: overview and practical use for clinicians","volume":"75","author":"Nahm","year":"2022","journal-title":"Korean J. Anesthesiol."},{"issue":"3","key":"10.1016\/j.ymgme.2025.109286_bb0150","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.3390\/ijms23031627","article-title":"Gaucher disease diagnosis using Lyso-Gb1 on dry blood spot samples: time to change the paradigm?","volume":"23","author":"Dinur","year":"2022","journal-title":"Int. J. Mol. Sci."}],"container-title":["Molecular Genetics and Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719225002781?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719225002781?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T13:31:44Z","timestamp":1768397504000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1096719225002781"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":30,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["S1096719225002781"],"URL":"https:\/\/doi.org\/10.1016\/j.ymgme.2025.109286","relation":{},"ISSN":["1096-7192"],"issn-type":[{"value":"1096-7192","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Correlation of Plasma Lyso-GL1 Levels with Clinical Phenotype and Treatment Decisions in Patients with Gaucher Disease","name":"articletitle","label":"Article Title"},{"value":"Molecular Genetics and Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymgme.2025.109286","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"109286"}}